Dual DOX-L system endowed with passive targeting (by virtue of size via EPR effect), better tumor penetration and intracellular delivery (by R8) and active targeting of TfRs over-expressed on the cancer cell-surface (by Tf via RME of TfRs) worked effectively to enhance therapeutic potential of DOX. This evidence concerns the gene TF and cancer.